Skip to main content

Table 1 Newcastle–Ottawa quality assessments scale

From: Prognostic role of galectin-3 expression in patients with solid tumors: a meta-analysis of 36 eligible studies

Studies

Year

Quality indicators from Newcastle–Ottawa Scale

Scores

1

2

3

4

5

6

7

8

Chou [20]

2018

★

–

★

★

★

★

★

★

7

Lu [10]

2017

★

★

★

★

★★

★

–

★

8

Huang [4]

2017

★

★

★

★

★

★

–

★

7

Li [11]

2017

★

★

★

★

★★

★

–

–

7

Shimura [41]

2017

★

★

★

★

★★

★

–

★

8

Wang [49]

2017

★

★

★

★

★

★

–

★

7

Liu [37]

2017

★

★

★

★

★★

★

–

–

7

Gopalan [21]

2016

★

★

★

★

★★

★

–

★

8

Ilmer [12]

2016

★

★

–

★

★★

★

–

★

7

Yang [48]

2016

★

★

★

★

★★

★

–

★

8

Tas [36]

2016

★

–

★

 

★★

★

–

★

7

Cheng [40]

2015

★

★

★

★

★★

★

★

–

7

Lu [47]

2015

★

★

★

★

★★

★

★

–

8

Jiang [22]

2014

★

★

★

★

★

★

★

★

8

Gomes [23]

2014

★

–

★

★

★★

★

★

★

8

Mu [44]

2013

★

★

★

★

★

★

–

★

7

Wu [45]

2013

★

★

★

★

★★

★

–

–

7

Liu [46]

2013

★

–

★

★

★

★

–

★

6

Yamaki [24]

2012

★

★

★

★

★★

★

★

–

8

Yang [25]

2012

★

–

★

★

★

–

–

★

5

Kim [26]

2012

★

★

★

★

★★

★

–

–

7

Kosacka [38]

2011

★

★

–

–

★★

★

★

–

6

Povegliano [27]

2010

★

★

★

★

★

★

–

★

7

Canesin [42]

2010

★

–

★

–

★★

★

–

★

6

Vereecken [43]

2009

★

★

★

–

★

★

–

★

6

Miranda [28]

2009

★

–

–

★

★★

★

★

–

6

Szoke [29]

2007

★

–

–

★

★

★

–

★

5

Kang [30]

2007

★

★

★

★

★

★

★

–

7

Moisa [39]

2007

★

★

–

★

★

–

★

★

6

Okada [13]

2006

★

★

★

★

★

★

–

★

7

Plzak [31]

2004

★

★

★

–

★

–

★

–

5

Piantelli [14]

2002

★

★

★

★

★★

★

★

–

8

Brule [32]

2000

★

–

★

★

★

★

★

–

6

Honjo [33]

2001

★

★

★

–

★

★

★

–

6

Nakamura [34]

1999

★

★

★

★

★★

★

–

★

8

Sanjuan [35]

1997

★

–

★

–

★

★

–

–

4

  1. 1. Representativeness of the exposed cohort; 2. Selection of the non-exposed cohort; 3. Ascertainment of exposure; 4. Outcome of interest not present at start of study; 5. Control for important factor or additional factor; 6. Assessment of outcome; 7. Follow-up long enough for outcomes to occur; 8. Adequacy of follow up of cohorts